AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
+47.8%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$95.1M
AUM Growth
+$95.1M
(+27%)
Cap. Flow
-$5.49M
Cap. Flow
% of AUM
-5.77%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Akebia Therapeutics
AKBA
|
$5.49M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Annexon
ANNX
$226M
| $53.1M | 55.85% | 7,406,024 | – | – |
|
|
2
Akebia Therapeutics
AKBA
$833M
| $24.2M | 25.42% | 13,205,119 -3,000,000 | -19% | -$5.49M |
|
3
American Well
AMWL
$111M
| $8.49M | 8.93% | 10,475,717 | – | – |
|
|
RNTX
4
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $5.51M | 5.79% | 830,466 | – | – |
|
|
WHWK
5
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.1M
| $3.82M | 4.01% | 1,630,830 | – | – |
|